CT26.WT: Murine Colon Carcinoma

MI9084 - CT26.WT Growth Curve
(actual study data; representative)
Implant Type
Implant Location
SC, High Axilla
Time to Staging
8 days
Time to 750mm3
13 days
2.8 days

(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.

***Please note that cell lines are not for sale and unavailable for purchase from Covance***

Fill out our tumor models contact form to get started setting up your next preclinical study with us.

Histotype: Colon

Tumor Line: Mouse

REF# 237C

Related Information:

High-Throughput Analysis of MAPK and JAK-STAT Signaling in CT26 Tumors Using a Combination of Immunophenotyping and Phospho-Flow Cytometry

Characterization of Proliferation in Multiple Lymphocyte Subsets in the CT26 Murine Colon Carcinoma Model by Multi-color Flow Cytometry

Combination of a GlycoMimetic Antagonist to E-Selectin and CXCR4, GMI-1359, with an Anti-PD-L1 Antibody Attenuates Regulatory T Cell Infiltration and Accelerates Time to Complete Response in the Murine CT26 Tumor Model

In-Depth Myeloid Cell Characterization in the Murine Syngeneic CT.26 Colon Carcinoma Model by 10-Color Flow Cytometry

CT26: Murine Colon Carcinoma